Description

COZARTAN 100 MG

Indications

COZARTAN 100 MG is primarily indicated for the management of hypertension in adults and pediatric patients aged 6 years and older. It is also used in the treatment of heart failure and to reduce the risk of stroke in patients with left ventricular hypertrophy. Additionally, COZARTAN is beneficial for patients with diabetic nephropathy, particularly in those with type 2 diabetes, to delay the progression of kidney disease.

Mechanism of Action

COZARTAN contains the active ingredient losartan, which is an angiotensin II receptor antagonist. It works by selectively blocking the action of angiotensin II, a potent vasoconstrictor that plays a crucial role in regulating blood pressure and fluid balance. By inhibiting the binding of angiotensin II to its receptors, COZARTAN causes vasodilation, reduces blood pressure, and decreases the secretion of aldosterone, leading to decreased sodium and water retention. This mechanism not only lowers blood pressure but also provides protective effects on the cardiovascular system and kidneys.

Pharmacological Properties

COZARTAN is well-absorbed after oral administration, with peak plasma concentrations occurring within 1 to 2 hours. The bioavailability of losartan is approximately 33%, and it undergoes extensive metabolism in the liver, primarily by cytochrome P450 2C9 to form its active metabolite, E3174, which has a longer half-life and is more potent than losartan itself. The elimination half-life of losartan is approximately 2 hours, while that of E3174 is about 6 to 9 hours. Both compounds are excreted primarily in the urine and feces.

Contraindications

COZARTAN is contraindicated in patients with a known hypersensitivity to losartan or any of the excipients in the formulation. It should not be used during pregnancy, particularly in the second and third trimesters, due to the risk of fetal harm. Additionally, it is contraindicated in patients with severe hepatic impairment and those with a history of angioedema related to previous treatment with an ACE inhibitor or angiotensin receptor blocker.

Side Effects

Common side effects associated with COZARTAN include dizziness, fatigue, and hypotension, particularly after the first dose. Other potential side effects may include headache, nasal congestion, and gastrointestinal disturbances such as diarrhea or abdominal pain. Rare but serious side effects can include renal impairment, hyperkalemia (elevated potassium levels), and angioedema. Patients should be monitored for these adverse effects, especially during the initiation of therapy or when the dosage is increased.

Dosage and Administration

The recommended starting dose of COZARTAN for the treatment of hypertension in adults is 50 mg once daily, which may be increased to 100 mg once daily based on blood pressure response. For patients with heart failure, the usual starting dose is 12.5 mg once daily, which can be titrated to a maximum of 150 mg daily. In pediatric patients aged 6 to 16 years, the dosage is based on body weight, with a typical range of 0.7 mg/kg to 1.4 mg/kg once daily, not exceeding 100 mg. COZARTAN can be taken with or without food, and patients are advised to adhere to the prescribed regimen for optimal results.

Interactions

COZARTAN may interact with several medications, which can alter its efficacy or increase the risk of adverse effects. Co-administration with potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium can lead to hyperkalemia. Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect of COZARTAN and increase the risk of renal impairment. Additionally, losartan may enhance the effects of other antihypertensive agents, necessitating careful monitoring and potential dosage adjustments. It is essential for patients to inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements.

Precautions

Before initiating treatment with COZARTAN, a thorough medical history and physical examination should be conducted. Caution is advised in patients with renal artery stenosis, as the use of losartan may lead to renal failure. Patients with a history of angioedema should be monitored closely, and COZARTAN should be discontinued immediately if signs of angioedema occur. Additionally, monitoring of serum electrolytes, particularly potassium, and renal function is recommended during treatment. It is also important to advise patients to remain hydrated and to report any symptoms of hypotension, such as dizziness or fainting.

Clinical Studies

Clinical studies have demonstrated the efficacy of COZARTAN in lowering blood pressure and improving cardiovascular outcomes. In a pivotal trial involving patients with hypertension, COZARTAN was shown to significantly reduce systolic and diastolic blood pressure compared to placebo. Furthermore, studies have indicated that COZARTAN is effective in reducing the incidence of stroke and myocardial infarction in patients with left ventricular hypertrophy. Other research has highlighted its protective effects on renal function in patients with diabetes, showing a reduction in the progression of nephropathy compared to conventional treatments.

Conclusion

COZARTAN 100 MG is a valuable therapeutic option for managing hypertension and related cardiovascular conditions. Its mechanism of action as an angiotensin II receptor antagonist provides effective blood pressure control and offers renal protection in high-risk populations. While generally well-tolerated, healthcare providers must be vigilant in monitoring for potential side effects and drug interactions. Individualized treatment plans and patient education are essential for optimizing therapeutic outcomes and ensuring safe use.